• 1
    Devesa SS, Grauman DG, Blot WJ, Pennello G, Hoover RN, Fraumeni JFJr. Atlas of cancer mortality in the United States, 1950–94. Washington, DC: US Government Printing Office; 1999: 129. NIH Publ. No. 99–4564.
  • 2
    Progress Review Groups. Conquering colorectal cancer: A blueprint for the future. Bethesda, MD: National Cancer Institute; 2000.
  • 3
    Pickle LW, Greene MH, Ziegler RG, et al. Colorectal cancer in rural Nebraska. Cancer Res. 1984; 44: 363369.
  • 4
    Willett W. The search for the causes of breast and colon cancer. Nature. 1989; 338: 389394.
  • 5
    Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell. 1990; 61: 759767.
  • 6
    Reddy B, Engle A, Katsifis S, et al. Biochemical epidemiology of colon cancer: Effect of types of dietary fiber on fecal mutagens, acid, and neutral sterols in healthy subjects. Cancer Res. 1989; 49: 46294635.
  • 7
    Potter JD. Reconciling the epidemiology, physiology, and molecular biology of colon cancer. JAMA. 1992; 268: 15731577.
  • 8
    Wynder EF, Reddy BS. Dietary fat and fiber and colon cancer. Semin Oncol. 1983; 10: 264272.
  • 9
    Lichtenstein P, Holm NV, Verkasalo PK, et al. Environmental and heritable factors in the causation of cancer-analyses of cohorts of twins from Sweden, Denmark, and Finland. N Engl J Med. 2000; 343: 7895.
  • 10
    Baker SG, Lichtenstein P, Kaprio J, Holm N. Genetic susceptibility to prostate, breast, and colorectal cancer among Nordic twins. Biometrics. 2005; 61: 5563.
  • 11
    Chu KC, Tarone RE, Chow WH, Alexander GA. Colorectal cancer trends by race and anatomic subsites, 1975 to 1991. Arch Fam Med. 1995; 4: 849856.
  • 12
    Arbes SJ, Olshan AF, Caplan DJ, et al. Factors contributing to the poor survival of black Americans diagnosed with oral cancer (United States). Cancer Causes Control. 1999; 10: 513523.
  • 13
    Krieger N, Quesenberry C, Peng T, et al. Social class, race/ethnicity, and incidence of breast, cervix, colon, lung and prostate cancer among Asian, black, Hispanic and white residents of the San Francisco Bay Area, 1988–92 (United States). Cancer Causes Control. 1999; 10: 525537.
  • 14
    Vlahov D, Ahern J, Vazquez T, et al. Racial/ethnic differences in screening for colon cancer: Report from the New York Cancer project. Ethn Dis. 2005; 15: 7683.
  • 15
    Troisi RJ, Freedman AN, Devesa SS. Incidence of colorectal carcinoma in the U.S.: An update of trends by sex, race, age, subsite, and stage, 1975–1994. Cancer. 1999; 85: 16701676.
  • 16
    Oh K, Willett WC, Fuchs CS, Giovannucci E. Dietary marine n-3 fatty acids in relation to risk of distal colorectal adenoma in women. Cancer Epidemiol Biomarkers Prev. 2005; 14: 835841.
  • 17
    Campos FG, Logullo Waitzberg AG, Kiss DR, Waitzberg DL, Habr-Gama A, Gama-Rodrigues J. Diet and colorectal cancer: Current evidence for etiology and prevention. Nutr Hosp. 2005; 20: 1825. Review.
  • 18
    Rose DP, Boyar AP, Wynder EL. International comparisons of mortality rates for cancer of the breast, ovary, prostate, and colon, and per capita food consumption. Cancer. 1986; 58: 23632371.
  • 19
    CDC. U.S. Cancer Statistics: Web-based incidence and mortality reports 1999–2001. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute; 2004.
  • 20
    Fulton JP, Wu XC, Carozza SE, et al. Variation in colorectal cancer incidence among states and metropolitan areas in the United States, 1991–1995, Cancer in North America, 1993–1997. Incidence. Volume One, 2005.
  • 21
    RiesLAG, KosaryCL, HankeyBF, MillerBA, CleggL, EdwardBK, eds. SEER cancer statistics review, 1973–1996. Bethesda, MD: National Cancer Institute; 1999.
  • 22
    Surveillance, Epidemiology, and End Results (SEER) Program. SEER*Stat Database: Incidence—SEER 9 Regs Public-Use, Nov 2004 Sub (1973–2002), National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch, April 2005, based on the November 2004 submission. Available at URL:
  • 23
    CDC. Behavioral risk factor surveillance system survey data. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention; 2001.
  • 24
    WHO. International Classification of Diseases for Oncology, 3rd edn. Geneva, Switzerland: World Health Organization; 2000.
  • 25
    Jackson-Thompson J, German RR, Ahmed F, Lai S, Friedman C. Descriptive epidemiology of colorectal cancer in the United States, 1998–2001. Cancer. 2006; 107,5 suppl( ).
  • 26
    Surveillance, Epidemiology, and End Results Program. Summary staging guide for the cancer Surveillance, Epidemiology, and End Results Reporting (SEER) program. Bethesda, MD: National Institute of Health, National Cancer Institute; 1997. NIH Pub. No. 86–2313 (reprinted July 1986).
  • 27
  • 28 Accessed December 2005.
  • 29
    SUDAAN. Software for the Statistical Analysis of Correlated Data, RTI International, Research Triangle Park, NC.
  • 30
    Breslow NE, Day NE. Statistical Methods in Cancer Research, Vol 2: The Design and Analysis of Cohort Studies. Lyon: IARC; 1987. IARC Scientific Publications No. 82.
  • 31
    Slattery ML. Physical activity and colorectal cancer. Sports Med. 2004; 34: 239252.
  • 32
    Luchtenborg M, Weijenberg MP, Kampman E, et al. Cigarette smoking and colorectal cancer: APC mutations, hMLH1 expression, and GSTM1 and GSTT1 polymorphisms. Am J Epidemiol. 2005; 161: 806815.
  • 33
    Engeland A, Tretli S, Austad G, Bjorge T. Height and body mass index in relation to colorectal and gallbladder cancer in two million Norwegian men and women. Cancer Causes Control. 2005; 16: 987996.